We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Guidance for Applicants wishing to apply for a Promising Innovative Medicines designation, pre-submission meeting or an EAMS Scientific Opinion.
Guidance on conditional marketing authorisations, exceptional circumstances marketing authorisations and national scientific advice.
A summary of the techniques and standards you should use to monitor ambient air.
The Advisory Committee on the Microbiological Safety of Food (ACMSF) is an independent scientific committee that provides expert advice to government on microbiological issues and food. ACMSF is an advisory non-departmental public body, sponsored by the Food Standards Agency and...
Information for patients, public and healthcare professionals.
AMRHAI (Antimicrobial Resistance and Healthcare Associated Infections) is the national reference unit for investigating antimicrobial resistance in healthcare-associated bacteria.
How to get a marketing authorisation (MA) for an advanced therapy medicinal product (ATMP) so it can be sold and/or supplied in the United Kingdom.
Scientific Advisory Committee on the Medical Implications of Less-Lethal Weapons has been replaced by Medical Implications of Less-Lethal Weapons Expert Committee . The Scientific Advisory Committee on the medical implications of less-lethal weapons (SACMILL) provides independent advice to UK government...
The MHRA accepts an Active Substance Master File and/or a Certificate of Suitability in both new national initial Marketing Authorisation Applications (MAA) and in Marketing Authorisation Variation (MAV) applications.
How an innovative funding mechanism is saving lives by speeding up the availability of vaccines and making them affordable.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).